Zeynab Yassin

Zeynab Yassin

Auto-generated profile, based on publicly available information

Zeynab Yassin

Antimicrobial Resistance Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2023 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
SSSanaz Shanbehzadeh
Sanaz Shanbehzadeh
NZNasibeh Zanjari
Nasibeh Zanjari
MYMarzieh Yassin
Marzieh Yassin
ZYZeynab Yassin
Zeynab Yassin
MTMahnaz Tavahomi
Mahnaz Tavahomi
Background: Older adults experience persistent symptoms post-COVID-19, termed as Long COVID, affecting their physical and mental health. This study aimed to evaluate the effects of Long COVID, level of physical activity, and functional decline on older adults’ health-related quality of life post-COVID-19. Methods: This cross-sectional study was conducted on 121 older adults with 60 to 90 years old post-coronavirus infection. The standardized metrics used in the study were Fatigue Severity Scale, Physical Activity Elderly, SF12, Post-COVID-19 functional status scale, and COVID-19 Yorkshire rehabilitation screening scale. The severity of coronavirus infection was evaluated by changes in chest CT scan images and O2 saturation at hospital admission. Data were analyzed using linear regression analyses. Results: The results of regression analysis revealed six factors to be predictors of physical health at 6 months post-COVID-19 (F = 9.046, P < 0.001; explained variance 63%), which the significant factors were fatigue, level of physical activity, worsened pain, difficulties in activities of daily living and cognitive-communication problems. Among these factors, greater fatigue and worsened pain intensity were the strongest predictors. Mental health was associated with days of hospitalization and cognitive-communication problems (F = 2.866, P < 0.001; explained variance 35%). Conclusions: Considering the negative impact of fatigue, pain, low physical activity, and cognitive-communication problems on health-related quality of life, early and accurate evaluation and management are required for recovered older adults post-COVID-19.

1 November 2016
Verified
Journal Article
Open access
ESEsfandiar Shojaei
Esfandiar Shojaei
ZYZeynab Yassin
Zeynab Yassin
Omid RezahosseiniOmid Rezahosseini
Omid Rezahosseini
Hydatid disease commonly involves liver but in rare cases, it can involve cardiac structures. A 75-yr-old farmer from Parsabad-Moghan, northwestern Iran was presented to the Emergency Room of Tehran Imam Khomeini Hospital, Tehran, Iran with dyspnea and without chest pain in 2014. A lesion compatible with hydatid cyst was found in echocardiography and confirmed by serology and MRI. Surgical treatment was done but the patient was died in recovery room because of cardiac arrhythmia. In endemic areas, hydatid cyst should be considered in differential diagnosis of heterogeneous echogenic lesions even if the serologic tests are negative. Physician can use cardiac MRI to earn valuable information about the lesion and its relation to other structures. However, with all of these assessments, surgical removal of cardiac cysts may have some complications.

28 July 2021 in Journal of Medical Virology
Verified
Journal Article
Open access
PDF file
SKSaeed Kalantari
Saeed Kalantari
SFSoheil R. Fard
Soheil R. Fard
DMDonya Maleki
Donya Maleki
MTMahshid T. Taher
Mahshid T. Taher
ZYZeynab Yassin
Zeynab Yassin
SMSara Minaeian
Sara Minaeian
The purpose of this study was to compare the effectiveness of Atazanavir/Ritonavir/Dolutegravir/Hydroxychloroquine and Lopinavir/Ritonavir/Hydroxychloroquine treatment regimens in COVID‐19 patients based on clinical and laboratory parameters. We prospectively evaluated the clinical and laboratory outcomes of 62 moderate to severe COVID‐19 patients during a 10‐day treatment plan. Patients were randomly assigned to either KH (receiving Lopinavir/Ritonavir [Kaletra] plus Hydroxychloroquine) or ADH (receiving Atazanavir/Ritonavir, Dolutegravir, and Hydroxychloroquine) groups. During this period, clinical and laboratory parameters and outcomes such as intensive care unit (ICU) admission or mortality rate were recorded. Compared to the KH group, after the treatment period, patients in the ADH group had higher activated partial thromboplastin time (aPTT) (12, [95% confidence interval [CI]: 6.97, 17.06), p = <0.01), international normalized ratio (INR) (0.17, [95% CI: 0.07, 0.27), p = <0.01) and lower C‐reactive protein (CRP) (−14.29, (95% CI: −26.87, −1.71), p = 0.03) and potassium (−0.53, (95% CI: −1.03, −0.03), p = 0.04) values. Moreover, a higher number of patients in the KH group needed invasive ventilation (6 (20%) vs. 1 (3.1%), p = 0.05) and antibiotic administration (27 (90%) vs. 21(65.6), p = 0.02) during hospitalization while patients in the ADH group needed more corticosteroid administration (9 (28.1%) vs. 2 (6.7%), p = 0.03). There was no difference in mortality rate, ICU admission rate, and hospitalization period between the study groups. Our results suggest that the Atazanavir/Dolutegravir treatment regimen may result in a less severe disease course compared to the Lopinavir/Ritonavir treatment regimen and can be considered as an alternative treatment option beside standard care. However, to confirm our results, larger‐scale studies are recommended.

20 November 2025 in Infection
Verified
Journal Article
Closed access
PDF file
SAShaghayegh Abaft
Shaghayegh Abaft
ZYZeynab Yassin
Zeynab Yassin
Mahdi AhmadiniaMahdi Ahmadinia
Mahdi Ahmadinia
AEAzadeh Eshraghi
Azadeh Eshraghi
BNBehnaz Gholizadeh Niari
Behnaz Gholizadeh Niari
ZYZeinab Yasin
Zeinab Yasin

1 October 2016 in Journal of Thoracic Disease
Verified
Journal Article
Closed access
PDF file
ZYZeynab Yassin
Zeynab Yassin
MSMohammad Saadat
Mohammad Saadat
HAHamidreza Abtahi
Hamidreza Abtahi
AFAbbas Rahimi Foroushani
Abbas Rahimi Foroushani
SPSoheil Peiman
Soheil Peiman
Background: There is little data about the correlation between the outcome of community acquired pneumonia (CAP) and the hypercapnic type respiratory failure. In this study we prospectively investigated the prognostic significance of first arterial CO2 tension in patients hospitalized with CAP. Methods: In this prospective study patients with CAP, admitted to a general hospital were included. PaCO2 was measured for each subject in an arterial blood sample drawn in the first 2 hours and its correlations with three major outcomes were evaluated: intensive care unit (ICU) admission, duration of admission and mortality in 30 days. Results: A total of 114 patients (mean age: 60.9±18.3; male: 51.8%) diagnosed with CAP were included. Significant relationship was not found between PaCO2 and mortality (P=0.544) or ICU admission (P=0.863). However advanced age, associated CHF, high BUN levels, high CURB-65 scores, associated pleural effusion in chest X-ray and being admitted to the ICU (P=0.012, 0.004, 0.003, <0.001, 0.045 and <0.001 respectively) were all significant prognostic factors of higher mortality risks. Prognostic factors for ICU admission were a history of malignancy (P=0.004), higher CURB-65 (P<0.001) scores and concomitant pleural effusion (P=0.028) in chest X-ray. Hypercapnic patients hospitalized for longer duration compared with normocapnic subjects. Furthermore, patients with lower pH (P=0.041) and pleural effusions (P=0.002) were hospitalized longer than the others. Conclusions: There was less prominent prognostic value regarding on-admission PaCO2 in comparison to other factors such as CURB-65. Considering the inconsistent results of surveys conducted on prognostic value of PaCO2 for CAP outcomes, further investigations are required to reach a consensus on this matter.

1 January 2016 in Journal of Infectious Diseases and Treatment
Verified
Journal Article
Open access
PDF file
ZYZeynab Yassin
Zeynab Yassin
ZAZahra Ahmadinejad
Zahra Ahmadinejad
HKHamid Emadi Kouchak
Hamid Emadi Kouchak
Background: The symptoms of pulmonary Tuberculosis include anorexia, weight loss, cough, night sweeting and fever. Fever is a common symptom and an efficient tool that is utilized for checking the response to anti-TB treatment. Objectives: The main goals of this study are evaluating the time of fever stop and effective factors on fever response according to anti tuberculosis treatment. Materials and methods: This study is a cross sectional study on tuberculosis (TB) patients hospitalized in the infectious diseases department of Imam Khomeini Complex Hospital (Tehran, Iran), from 1997 to 2006. We study the information related to 205 patients using the available database. Results: The median of the patients’ age is 40 years ranging from 15 to 88 and the average age is 45 years with standard deviation of 19.8. The average duration of fever response is 11.7 days with standard deviation of 7.5. No significant correlation was found among various factors such as: age, gender, different anti-tuberculosis regime, extra pulmonary or pulmonary TB, underlying disease, receiving immunesuppressing drugs, anemia, hyponatremia, history of drug addiction, and fever response followed by anti-TB treatment. Conclusion: The time of fever stop is relatively long in our patients following antituberculosis treatment. Due to similar prognosis between rapid and slow response in different patients, fever response should not be considered as a strict criterion for response to treatment and time of discharge.